Biora Therapeutics Inc (BIORQ)
Biora Therapeutics Inc. is a clinical-stage biotechnology company listed on OTC Markets under the ticker BIOR.Q. The company focuses on oral biotherapeutics and has developed two platforms: NaviCap, which is designed for targeted delivery of therapeutics in the gastrointestinal tract and is intended to support treatment of inflammatory bowel diseases, and BioJet, a systemic oral delivery platform aimed at providing needle-free delivery of large molecules for chronic disease management. The company was previously known as Progenity, Inc. and adopted its current name in April 2022 to reflect its therapeutics pipeline. Founded in 2010 and headquartered in San Diego, California, Biora Therapeutics filed for Chapter 11 bankruptcy on December 27, 2024, and its voluntary Chapter 11 petition was converted to Chapter 7 on May 27, 2025.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BIOR.Q
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.884 K
|
—
|
—
|
—
|
—
|
—
|
—
|
